Nidagest 5 mg (Tablet)

Indications

• Intra Uterine Growth Retardation (IUGR)
• Threatened abortion
• Habitual abortion
• Threatened premature delivery

Description

Nidagest is an oral Gestagen with a potent pregnancy-maintaining action without producing hormonal side-effects, stimulating the endocrine function of the trophoblast and placenta to produce more progesterone, and removing the threat of abortion with minimal side-effects.

Pharmacology

• Weak progestational effect on human endometrium
• Stimulates synthesis of progesterone in human placenta
• Increases production of specific placental enzymes
• Stimulates placental function
• Suppresses intensity of spontaneous uterine contractions in full-term pregnant women

Dosage & Administration

• 1 tablet three times a day for Intra Uterine Growth Retardation
• 1 tablet three times daily for Threatened abortion
• 1-2 tablets daily for Habitual abortion
• Dosage must be determined individually for Threatened premature delivery

Contraindications

• Breast Cancer or history of problem with the breasts
• Severe liver disease
• Undiagnosed vaginal bleeding
• Toxaemia of Pregnancy
• Crisis Seizures, Migraines

Side Effects

May cause gastrointestinal complaints such as vomiting, nausea, and epigastric discomfort

Pregnancy & Lactation

Designed for use during pregnancy, should be discontinued after delivery

Precautions & Warnings

Cautious use in patients with heart disease, seizures, renal dysfunction, migraine headaches, or breathing diseases; not recommended for breast-feeding

Use in Special Populations

Not for use in children younger than 16 years old

Overdose Effects

• Unusual drowsiness
• Rapid pulse
• Fainting
• Unusual muscle movement or rigidity
• Seizures
• Loss of consciousness

Therapeutic Class

Female Sex hormones

Storage Conditions

Keep below 30°C temperature, away from light & moisture; keep out of the reach of children

Related Brands

• Allygest 5 mg (Tablet) - nuvista-pharma-ltd
• Allynol 5 mg (Tablet) - popular-pharmaceuticals-ltd